InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Board Changes, Cease-Trade Order Update
December 6, 2022
RYAH Group (CSE: RYAH) today announced the appointment of Tanvir Malik Mukhtar, who brings two decades of experience working in leading financial institutions, as a member of its board of directors. “I have personally known Tanvir since 2015,” said RYAH’s Chief Executive Officer Dr. Dave Richards. “I’m highly confident that her enormous talent, intellect, leadership, […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Industry Veteran as New VP Overseeing IP Commercialization
August 31, 2022
RYAH Group (CSE: RYAH) has named a new vice president of intellectual property commercialization. The company has appointed Radka Milanova, PhD, to the new position; as a member of the senior management team, Milanova will work to ensure a consistent and strong focus on the company’s IP strategy, with an objective to expand and monetize […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Failure-to-File Cease Trade Order by Ontario Securities Commission
July 6, 2022
RYAH Group (CSE: RYAH) announced the issuance of a failure-to-file cease trade order (‘’FFCTO”) from the Canadian Securities Exchange. Effective immediately, the order is on trading of RYAH Group’s subordinated voting shares listed on the Canadian Securities Exchange. According to the announcement, RYAH had requested a management cease trade order (‘’MCTO”) from the exchange in […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Appoints New AVP of Investor Relations, Closes on Portion of Private Placement
June 28, 2022
RYAH Group (CSE: RYAH) has named Jules Gagnon as its AVP of investor relations, a role that includes responsibility for coordinating the company’s efforts to communicate and engage with investors. Gagnon has garnered impressive experience and a strong network of investors and capital market participants to the new role, and will direct activities on various […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Releases Update on Status of Proprietary Smart Inhalers
June 16, 2022
RYAH Group (CSE: RYAH) has reported the status of its business progress. The update was released by new management, which noted that lack of information had been an issue; the new management team anticipates providing regular updates regarding the business. The initial update covers RYAH’s flagship product, the Smart Inhaler, arguably the best dry herb […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) New CEO Shares Company Progress Report
June 13, 2022
RYAH Group (CSE: RYAH) CEO Dr. Dave Richards has released a report outlining key progress made during his first two months as CEO of the connected device and big data and technology company, which is focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. In the report, Richards notes that […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Four Strategic Appointments
June 1, 2022
RYAH Group (CSE: RYAH) today announced several key appointments. These include VP of Global Product Jordan Medley, AVP of Global Operations Sophie Kleshchuk, Senior Software Engineer Ramon Torres, and Research, Sales and Operations Associate Harry Tetteh. C. Jordan Medley is a founding member of RYAH and was the human intelligence driving the patented artificial intelligence […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Names New CFO, Corporate Secretary
April 26, 2022
RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced the appointment of a new chief financial officer and corporate secretary. The company named François C. Desrosiers, B. Com (Spec.) and FCSI, as Rryah CFO and […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Names New Director, CEO
April 12, 2022
RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced that its board of directors has nominated Dr. David R. Richards, PhD, FIoD, FRSA, CPsych, as a new director and the company’s chief executive officer. Richards […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Registration in New Zealand for Proprietary IoT System
March 15, 2022
RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a medical device certification in New Zealand for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). This comes in coordination with Medical Kiwi Ltd. […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Approval from Health Canada Recognizing RYAH Smart Medical Inhaler System as Medical Device
March 8, 2022
RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received a Health Canada Medical Device License (“MDL”) for its proprietary Internet of Things (“IoT”) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device (the “RYAH Smart Medical Inhaler System”). According to the update, Health Canada License number […]
RYAH Secures Health Canada Medical Device License for RYAH Smart Medical Inhaler System
RYAH Smart Medical Inhaler receives Health Canada Medical Device License for Company’s Smart Inhaler System Covered by the Health Canada Medical Device License (MDL) include the Inhaler device, proprietary cartridges and digital companion software that provide inhalation monitoring, patient feedback, and lab results of associated medical cannabis intake, with access to objective data The Canada […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Partners with University of Milan to Test, Evaluate New Line of Smart-Patch Wellness Products
February 17, 2022
RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, will be collaborating with the University of Milan, Italy, on a new wellness line of topical patches. The partnership will be testing the permeation and effectiveness of the […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Notice of Allowance by USPTO for Smart Medical Inhaler System
February 10, 2022
RYAH Group (CSE: RYAH) today announced that the U.S. Patent and Trademark Office (the “USPTO”) has issued a Notice of Allowance for U.S. patent application number 15/924,172, filed in respect of the company’s IoT-powered, Smart Medical Inhaler system by its wholly owned subsidiary, Potbotics Inc. The hybrid conduction and convection RYAH Smart Medical Inhaler was […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces MOU with Bazelet Pharma Ltd., Closing of Initial Tranche of Private Placement
January 27, 2022
RYAH Group (CSE: RYAH) today announced its entry into a memorandum of understanding (“MOU”) with Bazelet Pharma Ltd. and affiliates (together, “Bazelet”), the largest medical cannabis processing company in Israel, serving thousands of patients. According to the update, the collaboration is aimed at servicing Bazelet’s patients using RYAH Smart Inhalers and data analytics, once certified […]
InvestorNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Innovative Portfolio Powers Research Insights
January 5, 2022
RYAH Group (CSE: RYAH) is the leader in volume-control technology for plant-based medicine. The company supports cannabis research for the treatment of cancer “with innovative technology that collects, analyzes and leverages objective data on therapeutic plant usage. By using the company’s smart devices and integrated AI-powered platform, patients and doctors can stay on top of […]
InvestorNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) Smart Dry Herb Inhaler Providing Consistent, Predictable Results
December 27, 2021
RYAH Group (CSE: RYAH) develops innovative IoT products that capture powerful data insights and is on a mission to transform patient care using big data and AI to reshape the understanding and uses of plant-based medicines. The company’s devices and data are being used by a rapidly growing number of participants in plant-based clinical trials […]
RYAH Group Inc. (CSE: RYAH) Releases Medical Cannabis Report on Cancer and Adverse Cancer Treatment Effects
December 20, 2021
RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions RYAH supports cancer […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Collaborate with OMNI Medical Services for Cannabis Study in Treatment of COVID-19
December 16, 2021
RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced plans for a U.S. clinical study focused on treatment COVID-19. RYAH will be partnering with OMNI Medical Services to perform the U.S.-based clinical study evaluating patients […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Unearthing Breakthrough Discoveries That Will Reshape Understanding of Plant-Based Medicines
December 13, 2021
RYAH Group (CSE: RYAH) is a leading data technology company in plant-based medicine committed to providing valuable insight and transforming patient care through big data and artificial intelligence. According to a recent article, which contains excerpts from a RYAH blog post, “The company is working to unearth breakthrough discoveries that will reshape the understanding of […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Certification for IoT-Powered Dry Herb Inhaler, Software
December 8, 2021
RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received ISO 13485:2016/MDSAP and EN ISO 13485:2016 certification for its proprietary Internet of Things (“IoT”)-powered dry herb inhaler (the “RYAH Smart Inhaler”) and software application associated with the device. According to the update, the certification is a regulatory requirement and an international […]
RYAH Group Inc. (CSE: RYAH) to Deliver Solutions for Clinicians Examining Cannabis Efficacy in Cancer Treatment
December 7, 2021
Multiple ongoing studies are researching the relationship between medical cannabis and cancer treatment The viability of clinical studies within the sector is hampered by lack of exact measurement of a patient’s intake RYAH Group intends to resolve this issue with the launch of it’s proprietary RYAH Smart Dry Herb Inhaler The company successfully delivered on […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Refiling of Amended, Restated MD&A and Financial Statements
November 29, 2021
RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has amended, restated and refiled information covering the three and six months ended June 30, 2021. Information refiled includes RYAH’s management discussion and analysis (“MD&A”) and condensed, consolidated […]
RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market
Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Signs LOI to Develop Delivery Solutions for Psychoactive Compounds
November 15, 2021
RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, is partnering with Emotional Intelligence Ventures (Ei.Ventures), a leading psychedelic formulation and therapeutic research company. The collaboration is designed to evaluate the compatibility of RYAH’s proprietary Smart Patch […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Receives Additional Order as Its Ecosystem Continues to Power Trials, Pilots and Studies in Plant-Based Medicine
November 8, 2021
RYAH Group (CSE: RYAH) today announced its receipt of an additional order for future shipments of hundreds of its proprietary RYAH Smart Dry Herb Inhalers and accessories to its United Kingdom-based industry partner, an international clinic undertaking one of the world’s largest and most comprehensive clinical trials in plant-based medicine. The order follows the recently […]
German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study
November 5, 2021
German Social Democrat-led coalition expected to liberalize medical cannabis market Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028 RYAH entered German market via observational study with Four 20 Pharma GmbH RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications RYAH […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Enters LOI to Acquire Omni Services LLC
October 26, 2021
RYAH Group (CSE: RYAH) today announced its entry into a non-binding letter of intent (“LOI”) with Omni Services LLC (d/b/a “Omni Medical Services” or “Omni”), a leading physician-owned and operated telehealth, cannabis clinic and certifications company operating in the United States, with respect to the potential acquisition of 100% of the business and assets of […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Well Qualified to Provide Global Insight into Medical Cannabis
October 22, 2021
RYAH Group (CSE: RYAH), a connected device and big data and technology company, in a recent blog post provided insight into the cannabis medical space in Brazil, the largest South American country both in size and population, boasting a GDP per capita of $15,388. A recent article that contains excerpts from the post notes that […]
RYAH Group Inc. (CSE: RYAH) Positioned to Impact Palliative Care with AI-Powered Plant-Based Solutions
October 12, 2021
Palliative care focuses on providing end-of-life care for chronically ill patients Preliminary research suggests cannabis relieves pain, appetite loss, anxiety RYAH is the leader in volume-control technology for plant-based medicine RYAH’s ecosystem includes volume-control devices, medicine-carrying components, and AI-powered applications that capture and track data With a mission to advance remote-health solutions and analytics-based patient […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Providing Reliable, Consistent Dose Administration and Monitoring Devices
October 11, 2021
RYAH Group (CSE: RYAH), a connected device and big data and technology company, offers a suite of precision intake control and management devices that provide a practical way to execute volume control guidelines safely. In a company blog post, discussed in a recent article, RYAH noted that a global task force had created three separate […]
RYAH Group Inc. (CSE: RYAH) Reveals Attendance at the Wall Street Reporter’s Next Super Stock Livestream Conference
October 5, 2021
RYAH Group is a digital healthcare analytics and technology company focused on developing tools that provide patients and doctors with the ability to accurately manage the intake in plant-based treatment The company recently revealed its participation at the Wall Street Reporter’s ‘Next Super Stock’ livestream conference held on September 23, 2021 RYAH Group (CSE: RYAH) […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Present at LD Micro Conference
RYAH Group (CSE: RYAH) today announced that its CEO Gregory Wagner will be presenting at the virtual LD Micro conference on Tuesday, Oct. 12, 2021. The interactive online event is expected to give Wagner an opportunity to highlight RYAH’s mission and approach for the audience of investment community professionals and existing shareholders. Wagner’s presentation is […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Initiates Pilot Program with Four 20 Pharma in Germany
September 28, 2021
RYAH Group (CSE: RYAH) today announced that it has completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers for use in a pilot study to be conducted by Four 20 Pharma GmbH, a leading manufacturer, wholesaler and importer of medical cannabis and medical devices. The study is being conducted in preparation for […]
RYAH Group Inc. (CSE: RYAH) Provides Insight into Cannabis Medical Space in Brazil
Medical cannabis reform in Brazil is slowly taking shape Challenges include the cost of medical cannabis products and medical cannabis patients living close to available access With its background in connected devices, big data, and technology, RYAH appears well qualified to provide insight on medical cannabis around the world While the cannabis world’s attention is […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Present at Wall Street Reporter’s ‘Next Super Stock’ Livestream Conference
September 22, 2021
RYAH Group (CSE: RYAH) today announced that its Chief Executive Officer Gregory Wagner will be presenting at Wall Street Reporter’s “Next Super Stock” livestream conference on Thursday, Sept. 23, 2021. The online event is expected to give the investment community and existing shareholders an opportunity to interact in real time with Wagner and learn about […]
RYAH Group Inc. (CSE: RYAH) Devices Ideal for Implementation of New Cannabis Intake Control Recommendations
September 20, 2021
Research team uses Delphi process for the first time to identify ideal cannabis dosing guidelines. After several rounds of voting, the ‘global task force’ created three separate dosing protocols. RYAH Group’s suite of precision dosing devices provide a practical way to safely execute these — or any — recommended dosing guidelines. Dosing recommendations are critical […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Leveraging IoT Devices, AI Analytics to Provide Innovative Plant-Based Treatments
September 17, 2021
RYAH Group (CSE: RYAH), a connected device and big data and technology company, recently released a report outlining cannabis treatment options to address symptoms and conditions associated with HIV and AIDS. The report is based on information compiled by the RYAH Data Ecosystem, which enabled patients to submit data outlining symptoms they addressed with the […]
RYAH Group Inc. (CSE: RYAH) Publishes Report Outlining Cannabis Treatments for Conditions Associated with HIV and AIDS
September 10, 2021
RYAH releases report outlining ways cannabis is being used to treat conditions associated with HIV and AIDS Report data compiled by RYAH Data Ecosystem between January 1, 2018, and August 26, 2021 Data includes specific HIV and AIDS conditions, details cannabis strains used by patients Three-part RYAH Data Ecosystem includes volume control and management devices, […]
InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Featured in Visual Capitalist Spotlight
August 30, 2021
RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, was recently featured in a company spotlight on the Visual Capitalist. The piece highlights RYAH’s work to leverage data for powerful health solutions and references several drivers behind […]